Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Net Sales	$ 2,007.6	$ 1,949.5	$ 4,025.2	$ 3,921.9
Cost of products sold, excluding intangible asset amortization	583.7	527.7	1,159.5	1,040.6
Intangible asset amortization	149.5	147.7	300.3	299.7
Research and development	99.1	92.6	194.8	183.7
Selling, general and administrative	791.3	752.2	1,593.0	1,527.9
Intangible asset impairment		26.8		26.8
Acquisition, integration and related	50.5	72.5	96.5	130.7
Quality remediation	37.5	49.9	80.1	84.3
Operating expenses	1,711.6	1,669.4	3,424.2	3,293.7
Operating Profit	296.0	280.1	601.0	628.2
Other expense, net	(2.9)	(1.7)	(6.5)	(2.2)
Interest income	0.6	0.3	1.5	0.8
Interest expense	(75.9)	(82.3)	(154.8)	(165.2)
Earnings before income taxes	217.8	196.4	441.2	461.6
Provision (benefit) for income taxes	32.9	12.3	80.1	(21.8)
Net Earnings	184.9	184.1	361.1	483.4
Less: Net earnings (loss) attributable to noncontrolling interest	(0.1)	(0.1)	1.4	(0.2)
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 185.0	$ 184.2	$ 359.7	$ 483.6
Earnings Per Common Share
Basic	$ 0.91	$ 0.91	$ 1.77	$ 2.40
Diluted	$ 0.90	$ 0.90	$ 1.76	$ 2.38
Weighted Average Common Shares Outstanding
Basic	203.3	201.8	203.2	201.4
Diluted	204.6	203.7	204.6	203.4
Cash Dividends Declared Per Common Share	$ 0.24	$ 0.24	$ 0.48	$ 0.48